Search

Additional file 1: Table S1. Regional incident cases and ASIR of the three urologic benign diseases in 2019. Table S2 Regional deaths and ASMR of urinary tract infections and urolithiasis in 2019. Table S3 Regional DALYs and ASDR of the three urologic benign diseases in 2019. Table S4 Incidence, mortality, and DALYs of the three urologic benign diseases among the top three and bottom three countries in 2019. Table S5 EAPC of ASIR for the three urologic benign diseases in 203 countries and territories from 1990 to 2019. Table S6 EAPC of ASMR for urinary tract infections and urolithiasis in 203 countries and territories from 1990 to 2019. Table S7 EAPC of ASDR for the three urologic benign diseases in 203 countries and territories from 1990 to 2019.

Additional file 2: Fig. S1. Age-standardized DALYs rates for urolithiasis for 21 regions by SDI from 1990 to 2019. SDI sociodemographic index; DALYs disability-adjusted life-years. Fig. S2 Age-standardized mortality rates for urolithiasis for 21 regions by SDI from 1990 to 2019. SDI sociodemographic index. Fig. S3 Age-standardized incidence rates for urinary tract infections for 203 countries and territories by SDI in 2019. SDI sociodemographic index. Fig. S4 Age-standardized incidence rates for benign prostatic hyperplasia for 203 countries and territories by SDI in 2019.SDI sociodemographic index. Fig. S5 Age-standardized DALYs rates for urolithiasis for 203 countries and territories by SDI in 2019. SDI sociodemographic index; DALYs disability-adjusted life-years. Fig. S6 Age-standardized DALYs rates for benign prostatic hyperplasia for 203 countries and territories by SDI in 2019. SDI sociodemographic index; DALYs disability-adjusted life-years. Fig. S7 Age-standardized DALYs rates for urinary tract infections for 203 countries and territories by SDI in 2019. SDI sociodemographic index; DALYs disability-adjusted life-years. Fig. S8 Age-standardized mortality rates for urinary tract infections for 203 countries and territories by SDI in 2019. SDI sociodemographic index. Fig. S9 Age-standardized DALYs rates for urinary tract infections for 21 regions by SDI from 1990 to 2019. SDI sociodemographic index; DALYs disability-adjusted life-years. Fig. S10 Age-standardized mortality rates for urinary tract infections for 21 regions by SDI from 1990 to 2019. SDI sociodemographic index. Fig. S11 Age-standardized mortality rates for urolithiasis for 203 countries and territories by SDI in 2019. SDI sociodemographic index. Fig. S12 Age-standardized incidence rates for urinary tract infections for 21 regions by SDI from 1990 to 2019. SDI sociodemographic index. Fig. S13 Age-standardized incidence rates for benign prostatic hyperplasia for 21 regions by SDI from 1990 to 2019. SDI sociodemographic index. Fig. S14 Age-standardized DALYs rates for benign prostatic hyperplasia for 21 regions by SDI from 1990 to 2019. SDI sociodemographic index; DALYs disability-adjusted life-years. Fig. S15 Global incidence of the three urologic benign diseases by age and sex in 2019. a Urinary tract infections. b Urolithiasis. c Benign prostatic hyperplasia. Fig. S16 Global mortality of urinary tract infections and urolithiasis by age and sex in 2019. a Urinary tract infections. b Urolithiasis. Fig. S17 Global DALYs of the three urologic benign diseases by age and sex in 2019. a Urinary tract infections. b Urolithiasis. c Benign prostatic hyperplasia.